AGP Executive Report
Last update: 4 hours agoDutch Health Tech & Care Delivery: Amsterdam UMC research suggests patients with high-risk bowel polyps can safely wait five years for follow-up instead of three, potentially cutting tens of thousands of invasive exams annually. AI Regulation & Real-World Performance: A new FDA discussion paper spotlights the “proof problem” in medical AI—strong diagnostics don’t always translate into better patient outcomes, pushing regulators toward tighter pre- and post-use checks. Netherlands Health Innovation: A Dutch trial finds nurse-led protocolled care improves asthma control in children aged 6–12, with fewer uncontrolled cases. Semiconductors & Dutch Links: China advances sub-3nm chip work using older DUV tools as ASML EUV access remains blocked by sanctions. AI Hardware in the Netherlands: Tiny Dutch chipmaker Euclyd, backed by Samsung, raised $231M and targets enterprise AI inference hardware delivery in 2028. EU Crypto Regulation: EU banks doubled their MiCA register presence to about 80 institutions, boosting their share of listed crypto-asset providers to nearly 23%. Space & Safety: The EU SST space traffic program is gaining momentum as uncertainty grows around the US TraCSS system. Tech Talent in NL: Netherlands remains a top destination for global tech hiring despite tightening skilled-migrant sponsorship rules.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
